Herbal hope: salacia chinensis may curb appetite and sugar spikes
NCT ID NCT02929849
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether the herb Salacia chinensis, known to slow sugar absorption, can help control appetite and blood sugar in overweight or obese adults. Fifty-one participants took either a low or high dose of the herb or a placebo with a meal. Researchers measured appetite ratings and blood sugar levels to see if the herb made a difference.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Salacia chinensis (herbal supplement)
- What this could lead to
- If it works, this could point toward a natural supplement to help control appetite and blood sugar in people with obesity.
- What could go wrong
- This is a small, early-stage trial with only 51 participants. The effects may be small or not meaningful in real life, and supplements are not regulated like drugs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
51 people
The number who actually took part.
- Started
-
Aug 2015
- Finished
-
Jan 2017
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 59 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * BMI - overweight or stage 1 obesity * Must be willing and able to visit the geographic vicinity of New Brunswick, NJ Exclusion Criteria: * (BP) \[systolic BP\> 140 and/or diastolic BP\> 90\] * Fasting blood glucose \>126 * Subject has a significant history or current presence of treated or untreated bleeding disorder, diabetes mellitus, thyroid disease, tachyarrhythmia, heart disease, kidney disease, or liver disease. * History of chronic conditions and on prescription medication, surgery and or any treatment * Any significant GI condition that would severely interfere with the evaluation of the study product including but not limited to inflammatory bowel disease (Ulcerative Colitis or Crohn's), history of frequent diarrhea, history of surgery for weight loss (including gastric bypass or lapband), history of perforation of the stomach or intestines, gastroparesis, clinically important lactose intolerance * History or presence of all cancers in the prior two years. * Participation in a clinical study with exposure to any registered and non-registered drug product within 30 days prior. * Pregnant or lactating women. * Subjects who are currently on any weight loss diets, weight loss regimen * Subjects currently taking prescription medication for hypertension, cardiovascular disease, diabetes and/or other chronic conditions. * Subject currently suffers from a sleep disorder and/or has a known history of (or is currently being treated for) clinical depression, eating disorder(s) or any other psychiatric condition(s), which in the opinion of the investigator, might put the subject at risk and/or confound the results of the study. * Subject has a known allergy or sensitivity to any ingredient in the test product. * Subject has any medical condition or uses any medication, nutritional product, dietary supplement or program, which in the opinion of the investigator, might interfere with the conduct of the study or place the subject at risk. * Subject has a history of difficulty swallowing large pills or tablets. * Investigator is uncertain about subject's capability or willingness to comply with the protocol requirements.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Obesity are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Rutgers University
New Brunswick, New Jersey, 08901, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which exercise dose best helps kids with metabolic syndrome?
- Custom knee guides put to the test in obese patients
- A pill for obesity? early human trial puts MDR-001 to the test
- Can a weekly shot help people who still struggle with weight after bariatric surgery?
- Do GLP-1 Weight-Loss drugs change how teens eat and feel?
- Can electrical muscle stimulation boost exercise benefits after menopause?